Hypertension
Conditions
Interventions
None listed
Sponsors
Jichi Medical University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Hypertensive patients who receive treatment with antihypertensives
Exclusion criteria
Exclusion criteria: 1. Patients who have history of erebrovascular disease (exclude asymptomatic and transient) within 6 months before consent. 2. Patients with chronic renal failure in haemodialysis 3. Other seriously ill patients (e.g. end stage of cancer, active connective tissue disease) 4. dementia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset of Major cardiovascular events* *Major cardiovascular events; total death, cardiovascular death, sudden death, ischaemic heart disease (acute myocardial infarction, angina pectoris), cerebrovascular disease (cerebral infarction, cerebral embolism, cerebral hemorrhage, subarachnoid hemorrhage), aortic dissection, and hospitalization by heart failure | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)New onset of atrial fibrillation, peripheral arterial disease, renal function degeneracy(chronic dialysis), diabetes mellitus, and gouty attack. 2)Relationship between CV events and blood pressure variability related to environment (temperature and atmospheric pressure) and lifestyle (activity) 3)Change of antihypertensive treatment | — |
Countries
Japan
Contacts
Public ContactSatoshi Hoshide
Jichi Medical University School of Medicine Division of Cardiovascular Medicine, Department of Medicine
Outcome results
None listed